A PROTAC for MDM2, for example, consists of a nutlin-based MDM2 ligand joined to the E3 ubiquitin ligase cereblon (CRBN; CRL4CRBN) via a short linker and promotes efficient degradation of MDM2 in leukemia cells [164, 165]. Here, CRBN is linked to leukemia.